Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.57 |
| ▸ | PAM | P19021 | 1/20 | 0.57 |
| ▸ | MMP1 | P03956 | 1/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
| ▸ | MMP12 | P39900 | 1/20 | 0.56 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | TNKS | O95271 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3292040 | 0.91 | MEN1 (0.51) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL3292037 | 0.91 | MEN1 (0.51) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL28425115 | 0.91 | MMP1 (0.52) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL6649727 | 0.90 | LMNA (0.59) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL6823668 | 0.90 | LMNA (0.59) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL1158019 | 0.89 | MMP1 (0.51) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL1158016 | 0.89 | MMP1 (0.51) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL13923795 | 0.89 | MMP1 (0.51) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL293068 | 0.88 | IDO1 (0.57) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL3324115 | 0.88 | IDO1 (0.57) | IDO1PAMMMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116265438-B | Synthesis method of 5-HT6 receptor molecule based on C-N-axis indole olefin axial chirality | 南京理工大学 | 2024-10-29 | — | — | CN | claimed |
| CN-116265438-A | Synthesis method of 5-HT6 receptor molecule based on C-N-axis indole olefin axial chirality | 南京理工大学 | 2023-06-20 | — | — | CN | claimed |
| EP-2727915-B1 | Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof | CONCERT PHARMACEUTICALS INC (US) | 2016-04-13 | — | — | EP | claimed |
| EP-2727915-A1 | Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof | Concert Pharmaceuticals Inc. (US) | 2014-05-07 | — | — | EP | claimed |
| EP-4676937-A1 | METHODS OF SYNTHESIZING FLUORINATED MACROCYCLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-4419513-B1 | ANTITUMORAL COMPOUNDS | PHARMA MAR SA (ES) | 2025-08-27 | — | — | EP | disclosed |
| US-12384800-B2 | Antitumoral compounds | PHARMA MAR, S.A. (ES) | 2025-08-12 | — | — | US | disclosed |
| US-20250243174-A1 | ANTITUMORAL COMPOUNDS | PHARMA MAR, S.A. (ES) | 2025-07-31 | — | — | US | disclosed |
| WO-2025077996-A1 | SYNTHETIC PROCESS FOR THE MANUFACTURE OF ECTEINASCIDIN COMPOUNDS | PHARMA MAR, S.A. (ES) | 2025-04-17 | — | — | WO | disclosed |
| WO-2025050647-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 晟迪生物医药(苏州)有限公司 | 2025-03-13 | — | — | WO | disclosed |
| US-12215100-B2 | Anticancer compounds | PHARMA MAR, S.A. (ES) | 2025-02-04 | — | — | US | disclosed |
| CN-116265438-B | Synthesis method of 5-HT6 receptor molecule based on C-N-axis indole olefin axial chirality | 南京理工大学 | 2024-10-29 | — | — | CN | disclosed |
| EP-0941104-A4 | PEPTIDE SYNTHESIS WITH SULFONYL PROTECTING GROUPS | UNIV CALIFORNIA (US) | 2002-01-02 | — | — | EP | disclosed |
| US-6130349-A | USING COMPLEX OF MOLYBDENUM, TUNGSTEN OR CHROMIUM WITH 1,1*-BINAPHTHYL SYSTEM CONTAINING HETEROCYCLIC NITROGEN GROUP; ENANTIO- AND REGIOSELECTIVITY | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2000-10-10 | — | — | US | disclosed |
| WO-1999032225-A9 | CATALYTIC COMPOSITION BASED ON CHIRAL LIGANDS WITH MOLYBDENUM, TUNGSTEN OR CHROMIUM AND METHOD FOR ASYMMETRIC ALKYLATION OF ALLYLIC SUBSTRATES | UNIV LELAND STANFORD JUNIOR (US) | 1999-09-30 | — | — | WO | disclosed |
| EP-0941104-A1 | PEPTIDE SYNTHESIS WITH SULFONYL PROTECTING GROUPS | The Regents of the University of California (US) | 1999-09-15 | — | — | EP | disclosed |
| US-5859191-A | TREATING FREE TERMINAL ALPHA AMINE WITH ACTIVATING AGENT PRODUCING AMIDE WHICH IS DEPROTONATED WITH A BASE AND MODIFIED WITH AN ELECTROPHILE, THAN CLEAVING USING A NUCLEOPHILIC SUBSTUTION REACTION TO PROVIDE SECONDARY AMINE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-01-12 | — | — | US | disclosed |
| WO-1998024461-A1 | PEPTIDE SYNTHESIS WITH SULFONYL PROTECTING GROUPS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-06-11 | — | — | WO | disclosed |
| US-4851440-A | ASTHMA | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-07-25 | — | — | US | disclosed |
| EP-0260923-A2 | Temperature sensing composition | MEDICAL INDICATORS (a limited partnership under US law) (US) | 1988-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12384800-B2 | Antitumoral compounds | TP53, TOP1, MCL1 | IDO1 2586/4885PAM 3233/4885MMP1 1985/4885 |
| US-20250243174-A1 | ANTITUMORAL COMPOUNDS | MCL1, XPOT, GZMB | IDO1 1908/4885PAM 2007/4885MMP1 3028/4885 |
| US-12215100-B2 | Anticancer compounds | TP53, MCL1, MYC | IDO1 3595/4885PAM 4006/4885MMP1 3989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.